Hematologic Parameters as Predictors of Long-Term Mortality in Infective Endocarditis Patients

28 December 2023: Clinical Research

Sevil Gülaştı ^1ADEF* , Cemil Zencir ^1BCFG , Sercan Cayirli ^2ABC , Berk Mutlu ^1BCDF , Barcin Ozturk ^3BDFG

DOI: 10.12659/MSM.941758

Med Sci Monit 2023; 29:e941758

Table 1 Demographic and clinical characteristics of the patients with infective endocarditis.

	Three-year mortality		p
	Absent (n=70)	Present (n=85)	p
^#	61.5 [28.0–99.0]	70.0 [40.0–91.0]	^**
^##
Male	45 (64.3)	46 (54.1)	0.265^*
Female	25 (35.7)	39 (45.9)
^##	22 (31.4)	26 (30.6)	0.999^*
^##
Hypertension	34 (48.6)	44 (51.8)	0.815^*
Diabetes mellitus	30 (42.9)	35 (41.2)	0.962^*
Chronic renal failure	18 (25.7)	40 (47.1)	^*
Coronary artery disease	19 (27.1)	20 (23.5)	0.741^*
Cerebrovascular accident	5 (7.1)	5 (5.9)	0.755^*
Hyperlipidemia	3 (4.3)	2 (2.4)	0.659^*
Chronic obstructive pulmonary disease	1 (1.4)	2 (2.4)	0.999^*
^##	2 (2.9)	13 (15.3)	^*
^##
Previous infective endocarditis	8 (11.4)	3 (3.5)	0.067^*
Implantable cardiac devices	5 (7.1)	7 (8.2)	0.999^*
Recent history of tooth extraction	3 (4.3)	2 (2.4)	0.659^*
Degenerative valvular disease	4 (5.7)	4 (4.7)	0.999^*
Rheumatic heart disease	4 (5.7)	5 (5.9)	0.999^*
Prosthetic heart disease	16 (22.9)	23 (27.1)	0.679^*
^# Median [min–max]; ^## n (%); ^* Pearson Chi-Square, Fisher’s Exact, or Fisher Freeman Halton test; ^** Mann-Whitney U test.